Management of White Matter Hyperintensities Suggestive of Chronic Small Vessel Ischemic Disease

Initial Clinical Assessment and Risk Stratification

Routine repeat imaging is not recommended for stable, asymptomatic white matter changes, according to the American College of Rheumatology, as it does not provide additional information on disease progression 1, 2

The American College of Rheumatology recommends repeat imaging in patients with new neurological symptoms, such as focal deficits, cognitive decline, or stroke-like events, to assess disease progression 1
Imaging should also be considered in cases of clinical deterioration, such as progressive cognitive impairment or functional decline, although the strength of evidence for this is moderate 1
In patients with unclear inflammatory markers, such as elevated ESR/CRP without a clear infectious etiology, imaging may help differentiate active inflammation from chronic changes, with a low to moderate level of evidence 1

The American College of Rheumatology suggests establishing regular clinical follow-up every 3-6 months initially, focusing on monitoring for new neurological symptoms, cognitive changes, and vascular risk factor control, with a high level of evidence 1
Annual assessment is recommended thereafter if the patient is stable, with a moderate level of evidence 1
More frequent blood pressure monitoring, such as monthly or as needed, is necessary to ensure optimal control, with a high level of evidence 1

Over-imaging should be avoided in asymptomatic patients, as persistent imaging abnormalities do not necessarily indicate active disease requiring treatment escalation, according to the American College of Rheumatology, with a high level of evidence 1, 2